Evidence map›Paper›PMID 7964499›Full record

ArticleThe Journal of experimental medicine1994

A labile transcriptional repressor modulates endotoxin tolerance.

K E LaRue, C E McCall

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in The Journal of experimental medicine, 1994. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 113 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. RelB: an outlier in leukocyte biology.Journal of leukocyte biology · 2013
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. MicroRNA in TLR signaling and endotoxin tolerance.Cellular & molecular immunology · 2011
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

K E LaRueDepartment of Microbiology and Immunology, Bowman Gray School of Medicine, Wake Forest University, Winston-Salem, North Carolina 27157.
C E McCall
Wake Forest University · US

Funding

TRAINING PROGRAM IN IMMUNOLOGY AND PATHOGENESIST32AI007401 · NIAID · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI Martha Ann Alexander-Miller · 1991 to 2026
$4.4M
FUNCTIONAL AND METABOLIC PROPERTIES OF TOXIC NEUTROPHILSR01AI009169 · NIAID · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI MCCALL, CHARLES EMORY · 1985 to 2003
$1.3M
Function and Metabolic Properties of Toxic NeutrophilsR21AI009169 · NIAID · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI MCCALL, CHARLES EMORY · 2004 to 2004
$359k
NIAID NIH HHS 5T32-AI07401NIAID NIH HHS AI-09169
6 · The paper itself

Abstract

Tolerance to bacterial lipopolysaccharide (LPS, endotoxin) is an adaptive cellular process whereby exposure to endotoxin induces a subsequent hyporesponsive state characterized by decreased levels of LPS-induced cytokine mRNA and protein. We demonstrate, in a human promonocytic cell line, THP-1, that endotoxin tolerance is manifested by decreased LPS-induced interleukin 1 beta (IL-1 beta) transcription. Inhibition of protein synthesis reverses the tolerant phenotype by inducing transcription of IL-1 beta in the absence of a second stimulus. These results indicate that a labile protein contributes to the endotoxin-tolerant phenotype, and that this factor acts in a dominant repressive manner to inhibit the activity of existing transcription factors. We provide further data that cellular expression of I kappa B-alpha correlates with downregulated IL-1 beta gene expression during endotoxin tolerance, implicating I kappa B-alpha as a potential candidate for the labile repressor identified herein.

Indexed as

Blotting, NorthernCell LineCell NucleusCycloheximideDose-Response Relationship, DrugDrug ToleranceEmetineHumansInterleukin-1KineticsLipopolysaccharidesPuromycinRepressor ProteinsRNA, MessengerTetradecanoylphorbol AcetateTranscription, GeneticCycloheximideEmetineInterleukin-1LipopolysaccharidesPuromycinRepressor ProteinsRNA, MessengerTetradecanoylphorbol Acetate

Identifiers

PMID7964499
PMCPMC2191765
OpenAlexW1997564374

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.